Involvement of methylation of group of miRNA genes in regulation of expression of RAR-beta2 and NKIRAS1 target genes in lung cancer

Molecular Biology

Volumn 46, Issue 5, 2012, Pages 693-704

  Khodyrev, D S ^a   Pronina, I V ^a   Rykov, S V ^a   Beresneva, E V ^a   Freedman, M V ^a   Kazubskaya, T P ^b   Loginov, V I ^a   Braga, E A ^a  

^a STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

level of expression; methylation; methylation specific PCR; miRNA genes; mRNA; pri miRNA; primary lung tumors; RAR beta2 and NKIRAS1 target genes

Indexed keywords

EID: 84867320261     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S002689331205007X     Document Type: Article

References (58)

1. Lewis B. P., Burge C. B., Bartel D. P. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120, 15-20.
2. Bartel D. P. 2009. MicroRNAs: Target recognition and regulatory functions. Cell. 136, 215-233.
3. Janga S. C., Vallabhaneni S. 2011. MicroRNAs as post-transcriptional machines and their interplay with cellular networks. Adv. Exp. Med. Biol. 722, 59-74.
4. Sato F., Tsuchiya S., Meltzer S. J., Shimizu K. 2011. MicroRNAs and epigenetics. FEBS J. 278, 1598-1609.
5. Esquela-Kerscher A., Slack F. J. 2006. Oncomirs: MicroRNAs with a role in cancer. Nature Rev. Cancer. 6, 259-269.
6. Lee S. K., Calin G. A. 2011. Non-coding RNAs and cancer: New paradigms in oncology. Discov. Med. 11, 245-254.
7. Farazi T. A., Spitzer J. I., Morozov P., Tuschl T. 2011. miRNAs in human cancer. J. Pathol. 223, 102-115.
8. Munker R., Calin G. A. 2011. MicroRNA profiling in cancer. Clin. Sci. (London). 121, 141-158.
9. Han L., Witmer P. D., Casey E., Valle D., Sukumar S. 2007. DNA methylation regulates microRNA expression. Cancer Biol. Ther. 6, 1284-1288.
10. Lujambio A., Calin G. A., Villanueva A., Ropero S., Sanchez-Cespedes M., Blanco D., Montuenga L. M., Rossi S., Nicoloso M. S., Faller W. J., Gallagher W. M., Eccles S. A., Croce C. M., Esteller M. 2008. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl. Acad. Sci. U. S. A. 105, 13556-13561.
11. Rodriguez-Otero P., Román-Gómez J., Vilas-Zornoza A., José-Eneriz E. S., Martín-Palanco V., Rifón J., Torres A., Calasanz M. J., Agirre X., Prosper F. 2011. Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. Br. J. Haematol. 155, 73-83.
12. Rotkrua P., Akiyama Y., Hashimoto Y., Otsubo T., Yuasa Y. 2011. MiR-9 downregulates CDX2 expression in gastric cancer cells. Int. J. Cancer. 129, 2611-2620.
13. Gao X. N., Lin J., Li Y. H., Gao L., Wang X. R., Wang W., Kang H. Y., Yan G. T., Wang L. L., Yu L. 2011. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia. Oncogene. 30, 3416-3428.
14. UICC TNM Classification of Malignant Tumors, 6th ed. 2002. Eds. Sobin L. Y., Wittekind Ch. Chichester: Wiley-Liss.
15. Travis W. D., Coby T. V., Corrin B., Shimosato Y., Brambilla E. 1999. World Health Organization International Histological Classification of Tumours: Histological Typing of Lung and Pleural Tumours, 3rd ed. Berlin: Springer.
16. Herman J. G., Graff J. R., Myohanen S., Nelkin B. D., Baylin S. B. 1996. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 93, 9821-9826.
17. Loginov V. I., Khodyrev D. S., Pronina I. V., Malyukova A. V., Kazubskaya T. P., Ermilova V. D., Gar'kavtseva R. F., Zabarovskii E. R., Braga E. A. 2009. Two CpG islands in the SEMA3B gene: Methylation in clear cell renal cell carcinoma. Mol. Biol. (Moscow). 43(6), 1014-1018.
18. Ando T., Yoshida T., Enomoto S., Asada K., Tatematsu M., Ichinose M., Sugiyama T., Ushijima T. 2009. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: Its possible involvement in the formation of epigenetic field defect. Int. J. Cancer. 124, 2367-2374.
19. Bandres E., Agirre X., Bitarte N., Ramirez N., Zarate R., Roman-Gomez J., Prosper F., Garcia-Foncillas J. 2009. Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer. 125, 2737-2743.
20. Chomczynski P., Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal. Biochem. 162, 156-159.
21. Pronina I. V., Loginov V. I., Prasolov V. S., Klimov E. A., Khodyrev D. S., Kazubskaia T. P., Gar'kavtseva R. F., Sulimova G. E., Braga E. A. 2009. Alteration of SEMA3B gene expression levels in epithelial tumors. Mol. Biol. (Moscow). 43, 403-409.
22. Lee E. J., Gusev Y., Jiang J., Nuovo G. J., Lerner M. R., Frankel W. L., Morgan D. L., Postier R. G., Brackett D. J., Schmittgen T. D. 2006. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer. 120, 1046-1054.
23. Schmittgen T. D., Lee E. J., Jiang J., Sarkar A., Yang L., Elton T. S., Chen C. 2008. Real-time PCR quantification of precursor and mature microRNA. Methods. 44, 31-38.
24. Angeloni D., ter Elst A., Wei M. H., van der Veen A. Y., Braga E. A., Klimov E. A., Timmer T., Korobeinikova L., Lerman M. I., Buys C. H. 2006. Analysis of a new homozygous deletion in the tumor suppressor region at 3p12. 3 reveals two novel intronic noncoding RNA genes. Genes Chromosomes Cancer. 45, 676-691.
25. Glenn S. T., Jones C. A., Liang P., Kaushik D., Gross K. W., Kim H. L. 2007. Expression profiling of archival renal tumors by quantitative PCR to validate prognostic markers. Biotechniques. 43, 639-640.
26. Yang Q., Yoshimura G., Sakurai T., Nakamura M., Nakamura Y., Shan L., Suzuma T., Tamaki T., Umemura T., Mori I. and Kakudo K. 2001. Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor β2 expression in breast carcinoma. Breast Cancer Res. Treatment. 70, 39-45.
27. Selcuklu S. D., Yakicier M. C., Erson A. E. 2009. An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions. Cancer Genet. Cytogenet. 189, 15-23.
28. Wilson A. S., Power B. E., Molloy P. L. 2007. DNA hypomethylation and human diseases. Biochim. Biophys. Acta. 1775, 138-162.
29. Lujambio A., Ropero S., Ballestar E., Fraga M. F., Cerrato C., Setién F., Casado S., Suarez-Gauthier A., Sanchez-Cespedes M., Gitt A., Spiteri I., Das P. P., Caldas C., Miska E., Esteller M. 2007. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67, 1424-1429.
30. Kitano K., Watanabe K., Emoto N., Kage H., Hamano E., Nagase T., Sano A., Murakawa T., Nakajima J., Goto A., Fukayama M., Yatomi Y., Ohishi N., Takai D. 2011. CpG island methylation of microRNAs is associated with tumor size and recurrence of non-small-cell lung cancer. Cancer Sci. 102, 2126-2131.
31. Wang Z., Chen Z., Gao Y., Li N., Li B., Tan F., Tan X., Lu N., Sun Y., Sun J., Sun N., He J. 2011. DNA hypermethylation of microRNA-34b/c has prognostic value for stage I non-small cell lung cancer. Cancer Biol. Ther. 11, 490-496.
32. Watanabe K., Emoto N., Hamano E., Sunohara M., Kawakami M., Kage H., Kitano K., Nakajima J., Goto A., Fukayama M., Nagase T., Yatomi Y., Ohishi N., Takai D. 2012. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer. Int. J. Cancer. 130, 2580-2590.
33. Huang Y. W., Liu J. C., Deatherage D. E., Luo J., Mutch D. G., Goodfellow P. J., Miller D. S., Huang T. H. 2009. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res. 69, 9038-9046.
34. Shen R., Pan S., Qi S., Lin X., Cheng S. 2010. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer. Biochem. Biophys. Res. Commun. 394, 1047-1052.
35. Chen X., Hu H., Guan X., Xiong G., Wang Y., Wang K., Li J., Xu X., Yang K., Bai Y. 2012. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma. Int. J. Cancer. 130, 1607-1613.
36. Kozaki K., Imoto I., Mogi S., Omura K., Inazawa J. 2008. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 68, 2094-2105.
37. Loginov V. I., Malyukova A. V., Seryogin Y. A., Hodyrev D. S., Kazubskaya T. P., Ermilova V. D., Garkavtseva R. F., Kisselev L. L., Zabarovsky E. R., Braga E. A. 2004. Methylation of the promoter region of the RASSF1A candidate tumor suppressor gene in primary epithelial tumors. Mol. Biol. (Moscow). 38, 549-560.
38. Dreijerink K., Braga E., Kuzmin I., Geil L., Duh F.-M., Angeloni D., Zbar B., Lerman M. I., Stanbridge E. J., Minna J. D., Protopopov A., Li J., Kashuba V., Klein G., Zabarovsky E. 2001. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21. 3 is involved in kidney tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 98, 7504-7509.
39. Khodyrev D. S., Loginov V. I., Pronina I. V., Kazubskaya T. P., Garkavtseva R. F., Braga E. A. 2008. Methylation of promoter region of RAR-β2 gene in renal cell, breast, and ovarian carcinomas. Russ. J. Genet. 44, 983-988.
40. Lehmann U., Hasemeier B., Christgen M., Muller M., Romermann D., Langer F., Kreipe H. 2008. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J. Pathol. 214, 17-24.
41. Tanaka N., Toyooka S., Soh J., Kubo T., Yamamoto H., Maki Y., Muraoka T., Shien K., Furukawa M., Ueno T., Asano H., Tsukuda K., Aoe K., Miyoshi S. 2012. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. Lung Cancer. 76, 32-38.
42. Toyota M., Suzuki H., Sasaki Y., Maruyama R. 2008. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 68, 4123-4132.
43. Suzuki H., Yamamoto E., Nojima M. 2010. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis. 31, 2066-2073.
44. Tsai K. W., Wu C. W., Hu L. Y., Li S. C., Liao Y. L., Lai C. H., Kao H. W., Fang W. L., Huang K. H., Chan W. C., Lin W. C. 2011. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int. J. Cancer. 129, 2600-2610.
45. Tsai K. W., Liao Y. L., Wu C. W., Hu L. Y., Li S. C., Chan W. C., Ho M. R., Lai C. H., Kao H. W., Fang W. L., Huang K. H., Lin W. C. 2011. Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics. 6, 1189-1197.
46. Minor J., Wang X., Zhang F., Song J., Lu X., Gross N., Wang D., Lu S. L. 2012. Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncol. 48, 73-78.
47. Hildebrandt M. A., Gu J., Lin J., Ye Y., Tan W., Tamboli P., Wood C. G., Wu X. 2010. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene. 29, 5724-5728.
48. Lopes-Serra P., Esteller M. 2012. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene. 31, 1609-1622.
49. Braga E. A., Kashuba V. I., Maliukova A. V., Loginov V. I., Senchenko V. N., Bazov I. V., Kiselev L. L., Zabarovsky E. R. 2003. New tumor suppressor genes in hot spots of human chromosome 3: New methods of identification. Mol. Biol. (Moscow). 37, 170-185.
50. Loginov V. I., Bazov I. V., Khodyrev D. S., Pronina I. V., Kazubskaia T. P., Ermilova V. D., Gar'kavtseva R. F., Zabarovsky E. R., Braga E. A. 2008. Human chromosome 3P regions of putative tumor-suppressor genes in renal, breast, and ovarian carcinomas. Russ. J. Genet. 44, 209-214.
51. Zabarovsky E. R., Senchenko V., Loginov V., Pavlova T., Zabarovska V., Dmitriev A., Lung M., Panda C. K., Kashuba V., Lerman M. I., Braga E. A. 2011. Positional cloning of tumor suppressor genes from 3p21. 3 involved in major human cancers. Horiz. Cancer Res. 42, 103-127.
52. Braga E., Loginov W., Khodyrev D., Pronina I., Kazubskaya T., Bogatyrova O., Kashuba V. I., Senchenko V. N., Klein G., Lerman M. I., Kisselev L. L., Zabarovsky E. R. 2011. A novel MECA3 region in human 3p21. 3 harboring putative tumor suppressor genes and oncogenes. Exp. Oncol. 33, 33-41.
53. Braga E. A., Loginov V. I., Klimov E. A., Kilosanidze G., Khodyrev D. S., Kaganova N. L., Kazybskaia T. P., Ermilova V. D., Gar'kavtseva R. F., Pronina I. V., Rud'ko O. I., Zabarovsky E. R., Sulimova G. E., Kiselev L. L. 2006. Activation of RHOA gene transcription in epithelial tumors may be caused by gene amplification and/or demethylation of its promotor region. Mol. Biol. (Moscow). 40, 778-789.
54. Zabarovsky E. R., Braga E. A., Loginov V., Senchenko V., Kudryavtseva A., Dmitriev A., Khodyrev D., Pavlova T., Rynditch A. V., Lerman M. I., Kashuba V. 2011. Novel methylation-dependent markers/tumor suppressor genes involved in the development of renal cell cancer. Horiz. Cancer Res. 42, 129-152.
55. Khodyrev D. S., Loginov V. I., Pronina I. V., Kazubskaya T. P., Zabarovsky E. R., Braga E. A. 2011. Changes in methylation of genes from critical regions of chromosome 3 in epithelial tumors. Mol. Med. 1, 3-10.
56. Bhatti I., Lee A., Lund J., Larvin M. 2009. Small RNA: A large contributor to carcinogenesis? J. Gastrointest. Surg. 13, 1379-1388.
57. Hermeking H. 2010. The miR-34 family in cancer and apoptosis. Cell Death Differ. 17, 193-199.
58. Iliopoulos D., Rotem A., Struhl K. 2011. Inhibition of miR-193a expression by Max and RXR{alpha} activates K-Ras and PLAU to mediate distinct aspects of cellular transformation. Cancer Res. 71, 5144-5153.